Therapeutic angiogenesis with autologous stem/progenitor cells is a promising novel
strategy for treatment of severe ischemic diseases. Human clinical trials utilizing autologous …

Objective—Therapeutic angiogenesis using autologous stem/progenitor cells represents a
novel strategy for severe ischemic diseases. Recent reports indicated that adipose tissues …

Introduction: Therapeutic Angiogenesis by Cell Transplantation using autologous bone
marrow-derived mononuclear cells (TACT-BM) represents a novel strategy for critical limb …

Transplantation of adipose-derived regenerative cell (ADRC) enhances ischemia-induced
angiogenesis, but the underlying mechanism remains unknown. Here, we compared the …

We examined the protective effect of unsorted human adipose tissue-derived stem cells
(hADSCs) with a short-term culture in endothelial differentiation medium on tissue repair …

Background: Despite the growing knowledge regarding optimal treatments for critical limb
ischemia (CLI), there are still a considerable number of patients who have to undergo major …

Therapeutic angiogenesis has emerged as one of the most promising therapies for severe
ischemic cardiovascular diseases with no optional therapy. Several investigators have …

Using stem cell–conditioned medium (CM) might be a viable alternative to stem cell
transplantation, which is often hampered by low grafting efficiency and potential …

Objective Adipose-derived stem cells (ASCs) have angiogenic potential owing to their
differentiation into endothelial cells and their release of angiogenic growth factors to elicit …

Aim Adipose‐derived stem cells (ASCs) therapies are emerging as a promising approach to
therapeutic angiogenesis. Therapeutic persistence and reduced primitive stem cell function …